Quest for the right Drug
אקטרפיד ויאל ACTRAPID VIAL (INSULIN (HUMAN))
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי, תת-עורי : I.V, S.C
צורת מינון:
תמיסה להזרקה : SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Pharmaceutical particulars : מידע רוקחי
6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Glycerol Metacresol Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Zinc chloride Water for injections 6.2 Incompatibilities Insulin medicinal products should only be added to compounds with which it is known to be compatible. Medicinal products added to the insulin solution may cause degradation of the insulin, e.g. if the medicinal products contain thiols or sulfites. 6.3 Shelf life The expiry date of the product is indicated on the packaging materials Actrapid vial (100 international units/ml) During use or when carried as a spare: The product can be stored for a maximum of 6 weeks. Store below 25°C. Actrapid Penfill During use or when carried as a spare: The product can be stored for a maximum of 6 weeks. Store below 30°C. 6.4 Special precautions for storage Before opening: Store in a refrigerator (2°C – 8°C). Do not freeze. Actrapid vial (100 international units/ml) During use or when carried as a spare: Store below 25°C. Do not refrigerate or freeze.Keep the vial in the outer carton in order to protect from light. Actrapid Penfill During use or when carried as a spare: Store below 30°C . Do not refrigerate or freeze. Keep the cartridge in the outer carton in order to protect from light. 6.5 Nature and contents of container Actrapid vial (100 international units/ml) Vial (type 1 glass) closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution. Pack size of 1 vial of 10 ml. Actrapid Penfill Cartridge (type 1 glass) with a plunger (bromobutyl) and a rubber closure (bromobutyl/polyisoprene) containing 3 ml of solution. Pack size of 5 cartridges. . 6.6 Special precautions for disposal and other handling Do not use this medicinal product if you notice that the solution is not clear, colourless and aqueous. Actrapid which has been frozen must not be used. The patient should be advised to discard the needle and syringe after each injection. Any unused medicinal product or waste material should be disposed of in accordance with local requirements. Needles, syringes and cartridges must not be shared. The cartridge must not be refilled.
שימוש לפי פנקס קופ''ח כללית 1994
Diabetes mellitus, ketoacidosis & hyperosmolar nonketotic coma (insulin neutral)
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף